Reports for PFIZER CANADA ULC
Company Name
PFIZER CANADA ULC
Totals |
||
Shortage reports |
828 |
|
| Actual shortage: | 51 (6%) | |
| Anticipated shortage: | 12 (1%) | |
| Avoided shortage: | 52 (6%) | |
| Resolved: | 713 (86%) | |
Discontinuation Reports |
92 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 91 (99%) | |
| Reversed: | 1 (1%) | |
Late reports |
23 (3%) |
|
Overdue reports |
26 (41%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BLEOMYCIN FOR INJECTION USP | 15UNIT | POWDER FOR SOLUTION | Resolved | 2023-11-30 | 2024-04-10 | 212050 |
| BLEOMYCIN FOR INJECTION USP | 15UNIT | POWDER FOR SOLUTION | Resolved | 2020-02-05 | 2020-03-21 | 105370 |
| BLEOMYCIN FOR INJECTION USP | 15UNIT | POWDER FOR SOLUTION | Resolved | 2020-10-16 | 2020-11-17 | 126556 |
| BREVICON 0.5/35 TABLETS (21-DAY PACK) | 0.035MG 0.5MG | TABLET | Resolved | 2020-06-29 | 2021-03-10 | 119171 |
| BREVICON 0.5/35 TABLETS (21-DAY PACK) | 0.5MG 0.035MG | TABLET | Actual shortage | 2025-04-01 | 2025-04-17 | 253804 |
| BREVICON 0.5/35 TABLETS (21-DAY PACK) | 0.035MG 0.5MG | TABLET | Resolved | 2018-03-07 | 2018-04-24 | 42178 |
| BREVICON 0.5/35 TABLETS (21-DAY PACK) | 0.5MG 0.035MG | TABLET | Resolved | 2023-10-06 | 2023-10-26 | 206521 |
| BREVICON 0.5/35 TABLETS (28-DAY PACK) | .5MG .035MG | TABLET | Avoided shortage | 2024-07-17 | 2024-07-31 | 233215 |
| BREVICON 0.5/35 TABLETS (28-DAY PACK) | .5MG .035MG | TABLET | Anticipated shortage | 2025-04-17 | 2025-04-17 | 255238 |
| BREVICON 0.5/35 TABLETS (28-DAY PACK) | .5MG .035MG | TABLET | Resolved | 2024-05-03 | 2024-06-26 | 226997 |
| BREVICON 0.5/35 TABLETS (28-DAY PACK) | .5MG .035MG | TABLET | Resolved | 2023-10-06 | 2023-10-28 | 206524 |
| BREVICON 0.5/35 TABLETS (28-DAY PACK) | .035MG .5MG | TABLET | Resolved | 2020-06-29 | 2021-03-10 | 119176 |
| BREVICON 0.5/35 TABLETS (28-DAY PACK) | .035MG .5MG | TABLET | Resolved | 2018-02-28 | 2018-05-24 | 41332 |
| BREVICON 1/35 TABLETS (21-DAY PACK) | 0.035MG 1MG | TABLET | Resolved | 2024-06-14 | 2025-02-04 | 230652 |
| BREVICON 1/35 TABLETS (21-DAY PACK) | 0.035MG 1MG | TABLET | Anticipated shortage | 2025-04-17 | 2025-05-07 | 255235 |
| BREVICON 1/35 TABLETS (21-DAY PACK) | 0.035MG 1MG | TABLET | Resolved | 2023-03-28 | 2023-04-26 | 188193 |
| BREVICON 1/35 TABLETS (21-DAY PACK) | 0.035MG 1MG | TABLET | Resolved | 2018-02-21 | 2018-03-21 | 40436 |
| BREVICON 1/35 TABLETS (21-DAY PACK) | 0.035MG 1MG | TABLET | Resolved | 2023-06-20 | 2023-10-26 | 195942 |
| BREVICON 1/35 TABLETS (21-DAY PACK) | 1MG 0.035MG | TABLET | Resolved | 2020-06-29 | 2021-02-02 | 119179 |
| BREVICON 1/35 TABLETS (28-DAY PACK) | 0.035MG 1MG | TABLET | Resolved | 2023-05-29 | 2023-07-26 | 193321 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2021-06-09 | 2021-06-09 | 140591 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2018-08-14 | 2018-08-15 | 58099 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2018-08-14 | 2018-08-15 | 58096 |
| VIRACEPT | 625MG | TABLET TABLET | Discontinued | 2021-09-03 | 2021-10-29 | 145167 |
| VIRACEPT -250MG | 250MG | TABLET | Discontinued | 2021-09-03 | 2022-05-30 | 145163 |
| VIZIMPRO | 30MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180953 |
| VIZIMPRO | 45MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180956 |
| VIZIMPRO | 15MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180950 |
| ZITHROMAX | 250MG | TABLET | Discontinued | 2024-08-15 | 2024-08-16 | 235326 |
| ZITHROMAX | 250MG | TABLET | Discontinued | 2024-08-15 | 2024-08-16 | 235329 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2021-04-16 | 2021-04-17 | 137600 |
| ZYVOXAM 600 MG | 600MG | TABLET | Discontinued | 2020-01-17 | 2022-01-17 | 103480 |